Abstract
Adrenomedullin (AM) is a 52 amino acid peptide originally isolated from human pheochromocytoma. It was initially demonstrated to have profound effects in vascular cell biology, since AM protects endothelial cells from apoptosis, promotes angiogenesis and affects vascular tone and permeability. This review article summarizes the literature data concerning the relationship between AM and angiogenesis and describes the relationship between vascular endothelial growth factor, hypoxia and AM and tumor angiogenesis. Finally, the role of AM as a potential target of antiangiogenic therapy is discussed.
Publication types
-
Research Support, Non-U.S. Gov't
-
Review
MeSH terms
-
Adrenomedullin
-
Angiogenesis Inhibitors / therapeutic use
-
Animals
-
Gene Expression
-
Humans
-
Hypoxia / metabolism
-
Hypoxia / physiopathology
-
Neoplasms / blood supply
-
Neoplasms / drug therapy
-
Neovascularization, Pathologic / metabolism
-
Neovascularization, Pathologic / physiopathology*
-
Neovascularization, Physiologic / physiology*
-
Peptides / genetics
-
Peptides / metabolism
-
Peptides / physiology*
-
Vascular Endothelial Growth Factor A / genetics
-
Vascular Endothelial Growth Factor A / metabolism
Substances
-
Angiogenesis Inhibitors
-
Peptides
-
Vascular Endothelial Growth Factor A
-
Adrenomedullin